12 contracts

• CRESTONE, INC.SB

  TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018

  $33.1M

  Jan 31, 2027

  FY27 Q2 · 3 mo
  National Institutes of Health · NAICS 541714Record
• RHO FEDERAL SYSTEMS DIVISION INCSB

  AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)

  $40.1M

  Jan 31, 2027

  FY27 Q2 · 3 mo
  National Institutes of Health · NAICS 541714Record
• TECHNICAL RESOURCES INTERNATIONAL, INC.SB

  NIAID/DAIDS REGULATORY SUPPORT CENTER

  $56.6M

  Apr 14, 2027

  FY27 Q3 · 5 mo
  National Institutes of Health · NAICS 541714Record
• AVIAN, LLCSB

  UNFUNDED LABOR

  $65.5M

  Apr 30, 2027

  FY27 Q3 · 6 mo
  Department of the Navy · NAICS 541714Record
• VEDANTA BIOSCIENCES, INC.SB

  TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.

  $99.1M

  Aug 31, 2027

  FY27 Q4 · 10 mo
  Office of Assistant Secretary for Preparedness and Response · NAICS 541714Record
• PSYCHOGENICS INC.SB

  SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)

  $36.0M

  Sep 5, 2027

  FY27 Q4 · 10 mo
  National Institutes of Health · NAICS 541714Record
• CIDARA THERAPEUTICS INCSB

  DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA

  $58.1M

  Sep 29, 2027

  FY27 Q4 · 11 mo
  Office of Assistant Secretary for Preparedness and Response · NAICS 541714Record
• EITR BIOLOGICS, INC.SB

  THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI

  $33.1M

  Sep 30, 2027

  FY27 Q4 · 11 mo
  Office of Assistant Secretary for Preparedness and Response · NAICS 541714Record
• BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWILSB

  VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS.

  $45.2M

  Dec 31, 2027

  FY28 Q1 · 14 mo
  Office of Assistant Secretary for Preparedness and Response · NAICS 541714Record
• APTITUDE MEDICAL SYSTEMS INCSB

  ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND BEYOND

  $38.3M

  Dec 31, 2027

  FY28 Q1 · 14 mo
  Office of Assistant Secretary for Preparedness and Response · NAICS 541714Record
• TECHNICAL RESOURCES INTERNATIONAL, INC.SB

  CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION

  $317.1M

  Aug 21, 2028

  FY28 Q4 · 22 mo
  Office of Assistant Secretary for Preparedness and Response · NAICS 541714Record
• EMERGENT BIODEFENSE OPERATIONS LANSING LLCSB

  CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL

  $213.8M

  Oct 1, 2028

  FY29 Q1 · 23 mo
  Office of Assistant Secretary for Preparedness and Response · NAICS 541714Record

“Current end” is the end of the current period of performance in USAspending. Unexercised options can extend a contract, and agencies may recompete early or late — treat these dates as the start of your research, not a schedule.